Published in Mayo Clin Proc on January 01, 2010
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI2D) | NCT00006305
Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes. J Diabetes Complications (2012) 1.84
Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis (2013) 1.02
Refurbishing Mayo Clinic Proceedings: 2011-2012. Mayo Clin Proc (2011) 0.88
Observation on renal outcomes in the Veterans Affairs Diabetes Trial. Diabetes Care (2011) 0.83
Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitation. BMC Neurol (2012) 0.83
SOD2 gene Val16Ala polymorphism is associated with macroalbuminuria in Mexican type 2 diabetes patients: a comparative study and meta-analysis. BMC Med Genet (2013) 0.78
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80
The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med (2001) 2.67
Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol (2006) 2.51
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am Heart J (2008) 2.40
Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.60
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia (2000) 1.54
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke (1996) 1.29
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol (2003) 1.20
The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia (1976) 1.20
Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med (2004) 1.05
Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation (1992) 1.00
Angiographic study of coronary artery disease in diabetic patients in comparison with nondiabetic patients. Angiology (1999) 0.98
Diabetes mellitus: a cardiovascular disease. Curr Opin Investig Drugs (2003) 0.93
Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease. Diab Vasc Dis Res (2008) 0.91
Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol (2006) 0.90
Renal dysfunction is the most important predictor of the extent and severity of coronary artery disease in patients with diabetes mellitus. Coron Artery Dis (2007) 0.88
The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Arterioscler Thromb Vasc Biol (1997) 0.87
Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects. Coron Artery Dis (2001) 0.86
Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the Bypass Angioplasty Revascularization Investigation study (BARI). Am J Cardiol (1996) 0.81
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34
Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. N Engl J Med (2015) 5.81
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care (2002) 4.46
Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39
The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med (2003) 3.07
Extinct technetium in silicon carbide stardust grains: implications for stellar nucleosynthesis. Science (2004) 2.46
Pay for performance, public reporting, and racial disparities in health care: how are programs being designed? Med Care Res Rev (2007) 2.34
Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol (2011) 2.17
On-pump versus off-pump coronary artery bypass graft surgery among patients with type 2 diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial†. Eur J Cardiothorac Surg (2015) 2.00
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care (2003) 1.91
A comparison of physiochemical property profiles of development and marketed oral drugs. J Med Chem (2003) 1.81
Nutrition principles and recommendations in diabetes. Diabetes Care (2004) 1.78
Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation (2006) 1.75
Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association. Diabetes Care (2006) 1.65
Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res (2005) 1.60
Recent trials of antioxidant therapy: what should we be telling our patients? Cleve Clin J Med (2004) 1.58
Narrative review: a rational approach to starting insulin therapy. Ann Intern Med (2006) 1.57
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. J Am Coll Cardiol (2013) 1.55
Outcomes for resident-identified high-risk patients and resident perspectives of year-end continuity clinic handoffs. J Gen Intern Med (2012) 1.47
Peroral cholangioscopy: new approach with a balloon enteroscope. Endoscopy (2008) 1.42
Association between off-label use of drug-eluting stents and subsequent stent thrombosis: a case-control analysis. J Invasive Cardiol (2010) 1.42
Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). Am J Cardiol (2009) 1.42
Clinical implications of JUPITER in a contemporary European population: the EPIC-Norfolk prospective population study. Eur Heart J (2013) 1.41
Radar-enabled recovery of the Sutter's Mill meteorite, a carbonaceous chondrite regolith breccia. Science (2012) 1.41
Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J (2012) 1.27
Problems after discharge and understanding of communication with their primary care physicians among hospitalized seniors: a mixed methods study. J Hosp Med (2010) 1.26
The effect of obesity on quality of life in patients with diabetes and coronary artery disease. Am Heart J (2010) 1.21
Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation (2005) 1.21
Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs (2013) 1.19
Barriers related to mammography use for breast cancer screening among minority women. J Natl Med Assoc (2010) 1.18
Time-related differences in the physical property profiles of oral drugs. J Med Chem (2004) 1.18
Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res Clin Pract (2006) 1.18
Patient acuity rating: quantifying clinical judgment regarding inpatient stability. J Hosp Med (2011) 1.15
The supply and demand of chiropractors in the United States from 1996 to 2005. Altern Ther Health Med (2009) 1.15
Chemical predictive modelling to improve compound quality. Nat Rev Drug Discov (2013) 1.13
Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev (2011) 1.11
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2012) 1.04
Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem Res (2002) 1.01
The use of quality improvement and health information technology approaches to improve diabetes outcomes in African American and Hispanic patients. Med Care Res Rev (2010) 1.00
Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation (2013) 1.00
Estimating pneumonia deaths of post-neonatal children in countries of low or no death certification in 2008. PLoS One (2011) 1.00
VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol (1985) (2002) 0.99
The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Diabetes Care (2011) 0.98
An alternative method for the evaluation of docking performance: RSR vs RMSD. J Chem Inf Model (2008) 0.97
Clues from Fe isotope variations on the origin of early Archean BIFs from Greenland. Science (2004) 0.97
Impact of coronary artery calcification on all-cause mortality in individuals with and without hypertension. Atherosclerosis (2012) 0.97
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D). Am J Cardiol (2009) 0.97
A critical appraisal of the role of insulin analogues in the management of diabetes mellitus. Drugs (2005) 0.97
QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists. J Med Chem (2003) 0.96
Familial dyslipidaemias: an overview of genetics, pathophysiology and management. Drugs (2006) 0.96
Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease. Diabetes Metab Res Rev (2010) 0.95
Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency. J Bone Miner Res (2007) 0.95
Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia. Heart Lung Circ (2011) 0.95
Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction. Am J Physiol Heart Circ Physiol (2008) 0.94
Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling. Biochemistry (2006) 0.93
Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity. J Clin Endocrinol Metab (2004) 0.92
2006-2007 American Diabetes Association Nutrition Recommendations: issues for practice translation. J Am Diet Assoc (2007) 0.92
Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study. Atherosclerosis (2009) 0.92
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3. Biochim Biophys Acta (2005) 0.91
Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition (2010) 0.91
Cardiomyocytes overexpressing TNF-alpha attract migration of embryonic stem cells via activation of p38 and c-Jun amino-terminal kinase. FASEB J (2003) 0.91
Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis (2011) 0.91
Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial. J Am Coll Cardiol (2015) 0.90
-455G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement. Thromb Haemost (2005) 0.90
Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice. Sheng Li Xue Bao (2005) 0.90
Racial differences in the association between self-rated health status and objective clinical measures among participants in the BARI 2D trial. Am J Public Health (2010) 0.90
Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiovasc Surg (2006) 0.89
Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial. Diabetes Care (2014) 0.88
Insulin detemir is not transported across the blood-brain barrier. Peptides (2010) 0.88
Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects. Diabetes Res Clin Pract (2002) 0.87
Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention. J Am Coll Cardiol (2005) 0.87
Preliminary experience with bosentan as initial therapy in childhood idiopathic pulmonary arterial hypertension. J Heart Lung Transplant (2006) 0.87
Mortality risk as a function of the ratio of pulmonary trunk to ascending aorta diameter in patients with suspected coronary artery disease. Am J Cardiol (2013) 0.86
Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis. Pflugers Arch (2006) 0.86
The antioxidant paradox in diabetes mellitus. Am J Ther (2011) 0.86
The thermodynamics of the partitioning of ionizing molecules between aqueous buffers and phospholipid membranes. Pharm Res (2005) 0.86
Antioxidant vitamins and their influence in diabetes mellitus. Curr Diab Rep (2002) 0.86
Potential implications of coronary artery calcium testing for guiding aspirin use among asymptomatic individuals with diabetes. Diabetes Care (2012) 0.85
High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data. Am J Med Sci (2010) 0.85
The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes. Diabetes Care (2013) 0.84
Brugada syndrome caused by a large deletion in SCN5A only detected by multiplex ligation-dependent probe amplification. J Cardiovasc Electrophysiol (2011) 0.84
Increasing access to health care providers through medical home model may abolish racial disparity in diabetes care: evidence from a cross-sectional study. J Natl Med Assoc (2011) 0.84
Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study. Eur J Clin Invest (2013) 0.84
Relationship of dyspnea vs. typical angina to coronary artery disease severity, burden, composition and location on coronary CT angiography. Atherosclerosis (2013) 0.84
Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta. Biochim Biophys Acta (2003) 0.84
Effect of diabetes on the blood brain barrier. Curr Pharm Des (2003) 0.84
A rapid computational filter for cytochrome P450 1A2 inhibition potential of compound libraries. J Med Chem (2005) 0.83
The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis. Nutr Res (2011) 0.83
Insulin induction of apolipoprotein AI, role of Sp1. Biochemistry (2003) 0.83
Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells. Metabolism (2004) 0.82
Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models. J Comput Aided Mol Des (2007) 0.82